Education
About Us
Working with TipRanks
Follow Us
Atea Pharmaceuticals, Inc. (AVIR)
:AVIR
Bemnifosbuvir-Ruzasvir, Sofosbuvir-Velpatasvir
Hepatitis C, Chronic, Hepatitis C, Hepatitis C Virus Infection, Hepatitis C Virus Chronic Infection
Phase III
Recruiting
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
Jun 10, 2025
―
Treatment A-Bemnifosbuvir/Ruzasvir Fdc Administered Fasting, Treatment B-Omeprazole 20 Mg Dose Administered Fasting, Treatment C-Bemnifosbuvir/Ruzasvir Fdc Administered Simultaneously With 20 Mg Dose Of Omeprazole Fasting, Treatment D-Bemnifosbuvir/Ruzasvir Fdc Administered 0.5 Hour Prior To 20 Mg Dose Of Omeprazole, Treatment E-Omeprazole 40 Mg Administered Fasting, Treatment F-Bemnifosbuvir/Ruzasvir Fdc Administered 2 Hours After 40 Mg Dose Omeprazole
Healthy Volunteer Study
Phase I
Completed
Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir
May 19, 2025
―
Digoxin Vs Digoxin + Bem/Rzr Vs Digoxin + 2H Bem/Rzr, Rosuvastatin Vs Rosuvastatin + Bem/Rzr Vs Rosuvastatin + 2H Bem/Rzr
Healthy Volunteer Study
Phase I
Completed
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin
Mar 27, 2025
―
Bemnifosbuvir (Bem)/Ruzasvir (Rzr) As A Fixed-Dose Combination
Renal Impairment, Hepatic Impairment, Healthy Volunteer Study
Phase I
Recruiting
Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function
Mar 24, 2025
―
Bemnifosbuvir-Ruzasvir (Bem/Rzr), Sofosbuvir-Velpatasvir (Sof/Vel)
Hepatitis C Virus Chronic Infection
Phase III
Recruiting
C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV
Mar 07, 2025
―
Bemnifosbuvir, Ruzasvir
Hepatic Cirrhosis, Hepatitis C, Chronic, Hepatitis C, Chronic Hepatitis C Virus, Hcv
Phase II
Completed
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV
Jun 06, 2023
―
Bemnifosbuvir (Bem)
Covid-19, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars Cov 2 Infection)
Phase III
Completed
SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19
Nov 26, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Atea Pharmaceuticals, Inc. (AVIR) have in its pipeline
AVIR is currently developing the following drugs: Bemnifosbuvir-Ruzasvir, Sofosbuvir-Velpatasvir, Treatment A-Bemnifosbuvir/Ruzasvir Fdc Administered Fasting, Treatment B-Omeprazole 20 Mg Dose Administered Fasting, Treatment C-Bemnifosbuvir/Ruzasvir Fdc Administered Simultaneously With 20 Mg Dose Of Omeprazole Fasting, Treatment D-Bemnifosbuvir/Ruzasvir Fdc Administered 0.5 Hour Prior To 20 Mg Dose Of Omeprazole, Treatment E-Omeprazole 40 Mg Administered Fasting, Treatment F-Bemnifosbuvir/Ruzasvir Fdc Administered 2 Hours After 40 Mg Dose Omeprazole, Digoxin Vs Digoxin + Bem/Rzr Vs Digoxin + 2H Bem/Rzr, Rosuvastatin Vs Rosuvastatin + Bem/Rzr Vs Rosuvastatin + 2H Bem/Rzr. These drug candidates are in various stages of clinical development as the company works toward FDA approval.